Logo image of URE.CA

UR-ENERGY INC (URE.CA) Stock Fundamental Analysis

TSX:URE - Toronto Stock Exchange - CA91688R1082 - Common Stock - Currency: CAD

1.04  -0.05 (-4.59%)

Fundamental Rating

3

URE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 214 industry peers in the Oil, Gas & Consumable Fuels industry. URE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. URE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

URE had negative earnings in the past year.
In the past year URE has reported a negative cash flow from operations.
URE had negative earnings in each of the past 5 years.
In the past 5 years URE always reported negative operating cash flow.
URE.CA Yearly Net Income VS EBIT VS OCF VS FCFURE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

URE has a worse Return On Assets (-27.40%) than 74.77% of its industry peers.
Looking at the Return On Equity, with a value of -40.05%, URE is doing worse than 72.90% of the companies in the same industry.
Industry RankSector Rank
ROA -27.4%
ROE -40.05%
ROIC N/A
ROA(3y)-22.39%
ROA(5y)-20.85%
ROE(3y)-36.14%
ROE(5y)-36.97%
ROIC(3y)N/A
ROIC(5y)N/A
URE.CA Yearly ROA, ROE, ROICURE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

URE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
URE.CA Yearly Profit, Operating, Gross MarginsURE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

5

2. Health

2.1 Basic Checks

URE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for URE has been increased compared to 1 year ago.
URE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for URE has been reduced compared to a year ago.
URE.CA Yearly Shares OutstandingURE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
URE.CA Yearly Total Debt VS Total AssetsURE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

URE has an Altman-Z score of 0.19. This is a bad value and indicates that URE is not financially healthy and even has some risk of bankruptcy.
URE's Altman-Z score of 0.19 is on the low side compared to the rest of the industry. URE is outperformed by 64.02% of its industry peers.
URE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
URE has a Debt to Equity ratio of 0.01. This is in the better half of the industry: URE outperforms 77.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.19
ROIC/WACCN/A
WACC10.48%
URE.CA Yearly LT Debt VS Equity VS FCFURE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

URE has a Current Ratio of 5.99. This indicates that URE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of URE (5.99) is better than 91.59% of its industry peers.
URE has a Quick Ratio of 4.91. This indicates that URE is financially healthy and has no problem in meeting its short term obligations.
URE has a Quick ratio of 4.91. This is amongst the best in the industry. URE outperforms 89.25% of its industry peers.
Industry RankSector Rank
Current Ratio 5.99
Quick Ratio 4.91
URE.CA Yearly Current Assets VS Current LiabilitesURE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for URE have decreased strongly by -52.36% in the last year.
URE shows a strong growth in Revenue. In the last year, the Revenue has grown by 90.63%.
The Revenue has been growing slightly by 0.88% on average over the past years.
EPS 1Y (TTM)-52.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)90.63%
Revenue growth 3Y1090.03%
Revenue growth 5Y0.88%
Sales Q2Q%316.34%

3.2 Future

The Earnings Per Share is expected to grow by 34.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, URE will show a very strong growth in Revenue. The Revenue will grow by 44.12% on average per year.
EPS Next Y74.75%
EPS Next 2Y50.91%
EPS Next 3Y34.18%
EPS Next 5Y34.24%
Revenue Next Year-12.43%
Revenue Next 2Y75.41%
Revenue Next 3Y69.95%
Revenue Next 5Y44.12%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
URE.CA Yearly Revenue VS EstimatesURE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
URE.CA Yearly EPS VS EstimatesURE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

URE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for URE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
URE.CA Price Earnings VS Forward Price EarningsURE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
URE.CA Per share dataURE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as URE's earnings are expected to grow with 34.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.91%
EPS Next 3Y34.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for URE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UR-ENERGY INC

TSX:URE (5/5/2025, 7:00:00 PM)

1.04

-0.05 (-4.59%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-11 2025-04-11/amc
Earnings (Next)05-05 2025-05-05
Inst Owners83.84%
Inst Owner ChangeN/A
Ins Owners0.82%
Ins Owner ChangeN/A
Market Cap379.41M
Analysts80
Price Target2.37 (127.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-396.04%
Min EPS beat(2)-494.06%
Max EPS beat(2)-298.02%
EPS beat(4)1
Avg EPS beat(4)-230.53%
Min EPS beat(4)-494.06%
Max EPS beat(4)0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-20.65%
Min Revenue beat(2)-45.14%
Max Revenue beat(2)3.84%
Revenue beat(4)2
Avg Revenue beat(4)-35.31%
Min Revenue beat(4)-100%
Max Revenue beat(4)3.84%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.7%
PT rev (3m)-31.11%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-21.43%
EPS NY rev (3m)-325%
Revenue NQ rev (1m)-73.32%
Revenue NQ rev (3m)-58.39%
Revenue NY rev (1m)-35.81%
Revenue NY rev (3m)-49.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.15
P/FCF N/A
P/OCF N/A
P/B 2.07
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.13
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.4%
ROE -40.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.39%
ROA(5y)-20.85%
ROE(3y)-36.14%
ROE(5y)-36.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 289.75%
Cap/Sales 26.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.99
Quick Ratio 4.91
Altman-Z 0.19
F-Score1
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)127.22%
Cap/Depr(5y)82.73%
Cap/Sales(3y)1196.12%
Cap/Sales(5y)1907.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y74.75%
EPS Next 2Y50.91%
EPS Next 3Y34.18%
EPS Next 5Y34.24%
Revenue 1Y (TTM)90.63%
Revenue growth 3Y1090.03%
Revenue growth 5Y0.88%
Sales Q2Q%316.34%
Revenue Next Year-12.43%
Revenue Next 2Y75.41%
Revenue Next 3Y69.95%
Revenue Next 5Y44.12%
EBIT growth 1Y-104.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.62%
EBIT Next 3Y49.08%
EBIT Next 5Y35.54%
FCF growth 1Y-325.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-323.49%
OCF growth 3YN/A
OCF growth 5YN/A